Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat in Pediatric Relapsed Solid Tumors, Lymphoma, or Leukemia
NCT01422499Phase 2Completed
- Sponsor
- National Center for Tumor Diseases
- Start
- Mar 2012
- Primary completion
- Mar 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in solid tumor, lymphoma, leukemia, sponsored by National Center for Tumor Diseases. Started Mar 2012; status: completed.
02
Drugs
vorinostat
03
Conditions
solid tumorlymphomaleukemia
Beyond the preview
Go deeper on NCT01422499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01422499.